Fennec Pharmaceuticals Inc. employees and revenue per employee

FENC · Biotechnology · $372M market cap

Fennec Pharmaceuticals Inc. had 35 employees at the end of fiscal Dec 2025, up 9.4% from a year earlier. Revenue for the year was $44.6M, down 6.1% from a year earlier, or $1.28M per employee. Revenue fell while headcount grew.

Employees

35

+9.4% YoY

Revenue

$44.6M

-6.1% YoY

Revenue / employee

$1.28M

Peer median $459K

Rank in industry

27 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2020
01509630193'20'22'23'24'25Revenue 26260Staff 389

Hover a year for the numbers.

FENC employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 202535$44.6M$1.28M+9.4%-6.1%
Dec 202432$47.5M$1.49M+10.3%+123.7%
Dec 202329$21.3M$733K-19.4%+1284.5%
Dec 202236$1.5M$43K——
Dec 20209$170,000$19K——

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years
9'2036'2229'2332'2435'25
Revenue per employee, last six fiscal years
$19K'20$43K'22$733K'23$1.49M'24$1.28M'25

Fennec Pharmaceuticals Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
FENC
Fennec Pharmaceuticals Inc.
35$44.6M$1.28MHiring into decline
NKTR
Nektar Therapeutics
63$55.2M$877KHiring into decline
TNGX
Tango Therapeutics, Inc.
137$62.4M$455KLeaner
OBIO
Orchestra BioMed Holdings, Inc.
86$33.5M$389KEfficient growth
SEPN
Septerna Inc
130$46.0M$353KEfficient growth
PTGX
Protagonist Therapeutics, Inc.
132$46.0M$349KHiring into decline
KYMR
Kymera Therapeutics, Inc.
238$39.2M$165KHiring into decline
OCUL
Ocular Therapeutix, Inc.
325$51.8M$159KHiring into decline
AGIO
Agios Pharmaceuticals, Inc.
539$54.0M$100KEfficient growth
Every Healthcare company

Questions about Fennec Pharmaceuticals Inc.

How many employees does Fennec Pharmaceuticals Inc. have?
Fennec Pharmaceuticals Inc. reported 35 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 27, 2026. That is up 9.4% from a year earlier.
What is Fennec Pharmaceuticals Inc.'s revenue per employee?
Fennec Pharmaceuticals Inc. brought in $44.6M of revenue in fiscal Dec 2025, which is $1.28M per employee. That ranks 27 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare FENC with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Fennec Pharmaceuticals Inc.'s annual reports (Form 10-K), latest filed March 27, 2026. This is data, not a recommendation to buy or sell FENC.